EXTON, Pa., Jan. 25, 2022 /PRNewswire/ -- West Pharmaceutical
Services, Inc. (NYSE: WST), a global leader in innovative
solutions for injectable drug administration, today announced an
exclusive supply and technology agreement with Corning Incorporated
(NYSE: GLW). The new collaboration includes a multimillion-dollar
investment to expand Corning's Valor® Glass technology to enable
advanced injectable drug packaging and delivery systems for the
pharmaceutical industry with the goal of advancing patient safety
and expanding access to life-saving treatments.
![(PRNewsfoto/West Pharmaceutical Services, I) (PRNewsfoto/West Pharmaceutical Services, I)](https://mma.prnewswire.com/media/890850/west_pharma_large_Logo.jpg)
By combining West's industry-leading NovaPure® components, with
Daikyo Flurotec® coating technology, and Corning's Valor Glass and
Velocity® Vials, the strategic collaboration will enable new,
advanced pharmaceutical packaging solutions. The collaboration
optimizes the materials science and manufacturing expertise of both
companies to help bio-pharma producers navigate the complex
regulatory environment and mitigate risk in bringing drugs to
market.
"West and Corning have developed this exceptional collaboration
to offer leading elastomer-glass system solutions for the
containment and delivery of injectable medicines," said
Eric M. Green, President and Chief
Executive Officer, West. "At West, we value the state-of-the-art
products offered by Corning and are excited to build together the
next generation of integrated packaging and delivery
innovations."
This portfolio of new elastomer-glass system offerings and
supportive data services will utilize West's NovaPure components
along with Corning's Valor Glass technology. West's NovaPure
components adhere to Quality by Design principles and processing,
representing the highest standards in pharmaceutical components.
For customers, it provides the assurance of components with the
tightest specifications applicable within today's formulation and
manufacturing process capabilities at West. Corning's Valor Glass
is intended to enhance the storage and delivery of drugs, providing
more reliable access to state-of-the-art medicines essential to
public health. Valor Glass packaging can enable increased
throughput and offers high chemical durability, strength, and
damage resistance.
"This partnership and investment enable the development and
industry-leading solutions that enhance patient safety, increase
quality and reliability in highly regulated markets, and ensure
greater capacity for life-saving drugs. West is a great partner.
The combination of Corning's Valor Glass, along with West's
NovaPure components, is a win-win for customers and patients all
over the world," said Wendell P.
Weeks, Chairman and Chief Executive Officer, Corning.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, for
nearly a century, West helps ensure the safe, effective containment
and delivery of life-saving and life-enhancing medicines for
patients. Headquartered in Exton,
Pennsylvania, with almost 10,000 team members across 50
sites worldwide, West helps support our customers by delivering
over 40 billion components and devices each year. For more
information, visit www.westpharma.com.
About Corning Incorporated
Corning (www.corning.com) is one of the world's leading
innovators in materials science, with a 170- year track record of
life-changing inventions. Corning applies its unparalleled
expertise in glass science, ceramic science, and optical physics
along with its deep manufacturing and engineering capabilities to
develop category-defining products that transform industries and
enhance people's lives. Corning succeeds through sustained
investment in RD&E, a unique combination of material and
process innovation, and deep, trust-based relationships with
customers who are global leaders in their industries. Corning's
capabilities are versatile and synergistic, which allows the
company to evolve to meet changing market needs, while also helping
its customers capture new opportunities in dynamic industries.
Today, Corning's markets include optical communications, mobile
consumer electronics, display, automotive, and life sciences.
Trademarks and registered trademarks are the property of West
Pharmaceutical Services, Inc., in the United States and
other jurisdictions, unless noted otherwise.
Daikyo® are registered trademarks of Daikyo Seiko,
Ltd.
Corning® are registered trademarks of Corning
Incorporated.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-announces-landmark-collaboration-with-corning-in-pharmaceutical-injectable-drug-delivery-301467072.html
SOURCE West Pharmaceutical Services, Inc.